Most Read Articles
Roshini Claire Anthony, 4 days ago

Children who are fully vaccinated against the flu, ie, receive the recommended number of influenza vaccine doses, have a lower risk of acquiring influenza compared with those who are partially vaccinated, a US study found.

06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Surgical navigation preserves renal parenchyma in robot-assisted partial nephrectomy

27 Jun 2020

Surgical navigation improves renal parenchyma volume preservation in robot-assisted partial nephrectomy, potentially contributing to recovery in postoperative renal function, suggests a study.

The investigators developed surgical navigation with registration between real-time endoscopic images using 3-dimensional virtual reality models for robot-assisted partial nephrectomy and retrospectively analysed surgical outcomes of 44 (nonsurgical navigation group) and 102 (surgical navigation group) patients between June 2013 and December 2018. Propensity-score matching was carried out to adjust for potential baseline confounders.

Volumetric analysis was used to assess and compare renal parenchymal preservation rate and extraparenchymal volume with a tumour including functional and oncological outcomes (“trifecta” defined as warm ischaemia time of <25 minutes, no complications and negative surgical margins; “pentafecta” defined as trifecta plus >90 percent preservation of estimated glomerular filtration rate at 12 months postoperatively and chronic kidney disease up staging).

Each group had 42 participants after matching. No significant between-group differences were observed in baseline characteristics, complications; and intraoperative, trifecta, and pentafecta outcomes. In contrast, significant between-group differences were noted in pathological T stages (T1a/T1b/T2a or more 25/10/7 in the nonsurgical navigation group vs 35/7/0 in the surgical navigation group; p=0.003).

The surgical navigation group had significantly higher extraparenchymal volumes (21.4 vs 17.2 ml; p=0.041) and parenchyma volume preservation rates (90.0 percent vs 83.5 percent; p=0.042). In addition, surgical navigation positively correlated with improved parenchyma preservation volume (p=0.003).

Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Children who are fully vaccinated against the flu, ie, receive the recommended number of influenza vaccine doses, have a lower risk of acquiring influenza compared with those who are partially vaccinated, a US study found.

06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.